Common Contracts
2 similar Risk Sharing Agreement contracts
RISK SHARING AGREEMENT ON PRESCRIPTION DRUGS: 5 YEARS EXPERIENCE OF THE KOREA NATIONAL HEALTH INSURANCERisk Sharing Agreement • March 27th, 2018
Objectives: In 2014, the Korea National Health Insurance Service (NHIS) introduced the RSA (Risk Sharing Agreement) to ensure patient access to new drugs while holding the pharmaceutical industry responsible for the part of financial burden that could arise from uncertain performance of the drug. Only the prescription drugs indicated for cancer and rare diseases were eligible for the RSA. We aimed to document the outcomes of the RSA to inform the stakeholders of potential changes for cost-effective implementation of RSA. Methods: All the RSAs that the NHIS has finalized until June 1, 2019 were included. They were classified in terms of agreement type, indication, drug class (ATC 5 category), and the origin of the agreement holder. The agreement type was budget cap, fixed amount refund per unit sold and CED (Coverage with Evidence Development). The origin of the agreement holder was either domestic or global. The outcomes of RSA were examined in terms of adoption rates and post-implementati
RISK SHARING AGREEMENT ON PRESCRIPTION DRUGS: 5 YEARS EXPERIENCE OF THE KOREA NATIONAL HEALTH INSURANCERisk Sharing Agreement • March 27th, 2018
Objectives: In 2014, the Korea National Health Insurance Service (NHIS) introduced the RSA (Risk Sharing Agreement) to ensure patient access to new drugs while holding the pharmaceutical industry responsible for the part of financial burden that could arise from uncertain performance of the drug. Only the prescription drugs indicated for cancer and rare diseases were eligible for the RSA. We aimed to document the outcomes of the RSA to inform the stakeholders of potential changes for cost-effective implementation of RSA. Methods: All the RSAs that the NHIS has finalized until June 1, 2019 were included. They were classified in terms of agreement type, indication, drug class (ATC 5 category), and the origin of the agreement holder. The agreement type was budget cap, fixed amount refund per unit sold and CED (Coverage with Evidence Development). The origin of the agreement holder was either domestic or global. The outcomes of RSA were examined in terms of adoption rates and post-implementati
